Zydus Lifesciences Ltd share price logo

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

BSE: 532321

Large Cap

Healthcare Sector

Pharma Sector

₹1120.00

-23.00

(-2.01%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Zydus Lifesciences Stock Performance

as on September 4, 2026 at 9:31 pm IST

  • Day's High

    ₹1,120.00
    ₹1,146.00

    2.32%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹835.50
    ₹1,205.00
    downward going graph

    25.40%

    Downside

    7.59%

    Upside

    downward going graph

Zydus Lifesciences share price movements today

Previous Close
₹1,143.00
Open
₹1,146.00
Volume
5.17L
Upper Circuit
₹1,159.10
Lower Circuit
₹1,091.70
Day's Low - High
₹1,120.00 - ₹1,146.00
52 Week Low - High
₹835.50 - ₹1,205.00

Zydus Lifesciences Historical Returns

1 Month Return
-0.1 %
3 Month Return
+ 2.85 %
1 Year Return
+ 10.47 %
3 Year Return
+ 76.64 %
5 Year Return
+ 101.11 %

Zydus Lifesciences Fundamentals

as on September 4, 2026 at 4:01 pm IST

Market Cap

₹1,11,720.43 Cr

Return on Equity (ROE)

15.87

PE Ratio (TTM)

25.47

Return on capital employed (ROCE)

15.9

Industry PE ratio

-

Beta (LTM)

0.67

P/B Ratio

3.7

Dividend Yield

0

PEG Ratio

-43.92

Quarterly Earnings Growth YOY

-35.93

EPS (TTM)

49.96

Book Value

269.5

Zydus Lifesciences Technical Analysis

Track how Zydus Lifesciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish10
Bullish2
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.48
Bullish
CCI (20)
-46
Neutral
RSI (14)
46.6
Neutral
Momentum (10)
0
Bearish
ADI (14)
49.55
Bearish
Ultimate Oscillator (7,14,28)
47.93
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1124.27
Bearish
EMA (20)
1124.43
Bearish
VWMA (20)
1124.06
Bullish
SMA (50)
1125.81
Bearish
EMA (50)
1125.66
Bearish
SMA (200)
1129.63
Bearish
EMA (200)
1129.2
Bearish
KAMA (200)
1126.1
Bearish
DEMA (200)
1125.96
Bearish

Zydus Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,14,014.6921.05%0.695,02651,180
Sanofi India Ltd image
Sanofi India Ltd
BUY7,348.41-12.42%0.004132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY94,206.6223.39%0.603,50233,653
Abbott India Ltd image
Abbott India Ltd
BUY55,133.136.45%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY49,763.0219.18%0.561,0353,821
See all

Market expectation of Zydus Lifesciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

53.33%

Buy

23.33%

Hold

23.33%

Sell

Zydus Lifesciences Stock’s Investor Sentiment and Interest

Investment in Zydus Lifesciences Ltd Shares on INDmoney has grown by 38.47% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:38.47% versus previous 30 day period

Search interest for Zydus Lifesciences Ltd Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Zydus Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
4,258.6
4,343.7
5,366.4
6,046.5
5,113.6
5,123.5
6,290.2
6,467
6,037.9
6,780.4
7,434.4
7,802
Other Income
54
59.5
159.6
63.2
68.5
57.5
80.6
154.9
109
111.4
134.2
106.1
Total Income
4,422.8
4,564.7
5,693.4
6,270.7
5,305.5
5,326.6
6,608.5
6,728.6
6,232.2
6,975.9
7,721.2
8,123.1
Expenses
3,223.7
3,402.8
3,903.3
4,123.5
3,775.6
3,881.8
4,622
4,485.2
4,141.6
5,133
5,430.1
6,105.8
Operating Profit
1,034.9
940.9
1,463.1
1,923
1,338
1,241.7
1,668.2
1,981.8
1,896.3
1,647.4
2,004.3
1,696.2
Operating Profit Margin %
24.3%
21.66%
27.26%
31.8%
26.17%
24.24%
26.52%
30.64%
31.41%
24.3%
26.96%
21.74%
Profit Before Interest, Tax and Depreciation
1,199.1
1,161.9
1,790.1
2,147.2
1,529.9
1,444.8
1,986.5
2,243.4
2,090.6
1,842.9
2,291.1
2,017.3
Interest
8.7
19.8
34.6
32.2
25.1
32
76.6
84.7
101.3
129.9
123
156
Depreciation
184.2
194.8
205.3
215.3
233.6
229
237.9
238.1
301.9
359.6
508.4
554.7
Profit Before Tax
1,006.2
947.3
1,550.2
1,899.7
1,271.2
1,183.8
1,672
1,920.6
1,687.4
1,353.4
1,659.7
1,306.6
Tax Paid
226.4
213.8
321.2
436.1
373.1
179.5
423.2
434
454
388.3
318.4
354.2
Profit After Tax
779.8
733.5
1,229
1,463.6
898.1
1,004.3
1,248.8
1,486.6
1,233.4
965.1
1,341.3
952.4
Total Net profit including share of profit / Loss from associate company
803.2
789.9
1,246.1
1,482.5
920.2
1,026.2
1,243.7
1,521
1,238.6
1,022.9
1,341
990.2
EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
9.35
Actual EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
9.35
Adjusted EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
9.35
Diluted EPS
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
9.35

Zydus Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
11,581.3
12,748.4
13,812.1
14,125
14,827.6
16,877.8
19,021.5
22,573.8
26,719.7
Other Income
113.2
201.1
113.9
45.6
2,583.1
186.6
307.1
269.5
509.5
Total Income
12,018.1
13,366.7
14,367
14,449.1
17,693
17,424
19,854.5
23,511
27,657.9
Expenses
9,076.2
10,192.5
11,833.3
11,289.5
11,769.2
13,986.3
14,177.3
16,402.6
19,189.9
Operating Profit
2,505.1
2,555.9
1,978.8
2,835.5
3,058.4
2,891.5
4,844.2
6,171.2
7,529.8
Operating Profit Margin %
21.63%
20.05%
14.33%
20.07%
20.63%
17.13%
25.47%
27.34%
28.18%
Profit Before Interest, Tax and Depreciation
2,941.9
3,174.2
2,533.7
3,159.6
5,923.8
3,437.7
5,677.2
7,108.4
8,468
Interest
91.1
193.5
341.8
158.8
127
129.9
81.2
165.9
438.9
Depreciation
538.8
598.6
696.5
669.6
713
722.7
764.1
915.8
1,408
Profit Before Tax
2,312
2,382.1
1,495.4
2,331.2
5,083.8
2,585.1
4,831.9
6,026.7
6,621.1
Tax Paid
564.4
530.3
319.8
193.6
511.7
587.8
977.5
1,411.9
1,594.7
Profit After Tax
1,747.6
1,851.8
1,175.6
2,137.6
4,572.1
1,997.3
3,854.4
4,614.8
5,026.4
Total Net profit including share of profit / Loss from associate company
1,810.4
1,898.7
1,204.4
2,185
4,618.3
2,091.9
3,972.8
4,672.6
5,123.5
EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09
Actual EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09
Adjusted EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09
Diluted EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
50.09

Zydus Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,893.5
1,311.7
919.3
1,281.9
2,505.4
3,293
2,104.1
2,688.8
3,227.9
6,781.1
2,116.6
Cash Flow from Investing Activities
-859.6
-2,871.9
-973.7
-3,977.4
-1,012.3
-834.6
1,137.1
1,177.8
-1,492.3
-8,362.6
-7,895.1
Cash Flow from Financing Activities
-934.8
2,315.8
51.5
1,884.6
-1,094.2
-2,548.9
-868.3
-4,400.4
-1,810.4
1,995.3
5,806.9
Net Cash Flow
99.1
755.6
-2.9
-810.9
398.9
-90.5
2,372.9
-533.8
-74.8
413.8
28.4

Zydus Lifesciences Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
74.98%
74.98%
74.98%
74.98%
74.98%
74.99%
74.99%
74.99%
75%
75%
75.01%
DII
12.79%
12.63%
12.64%
10.65%
10.65%
11.01%
11.13%
10.86%
11.09%
11.2%
11.27%
FII
0%
5.72%
5.59%
7.52%
7.53%
7.32%
7.13%
7.34%
7.06%
6.95%
6.88%
Public
6.99%
6.66%
6.8%
6.85%
6.84%
6.68%
6.74%
6.8%
6.85%
6.86%
6.83%
Total Outstanding Shares
1,01,22,04,139
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
99,75,03,832
Total Shareholders
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105
4,03,266
4,18,314
3,99,251

Mutual Funds that own Zydus Lifesciences Stock

Check out the Mutual Funds with significant holdings in Zydus Lifesciences.

Zydus Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of Zydus Lifesciences.

  • Zydus Lifesciences Ltd Earnings Results

    Zydus Lifesciences Ltd’s net profit fell -35.93% since last year same period to ₹939.80Cr in the Q1 2026-2027. On a quarterly growth basis, Zydus Lifesciences Ltd has generated -26.15% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Zydus Lifesciences Ltd Dividends May,2026

    In the quarter ending March 2026, Zydus Lifesciences Ltd has declared dividend of ₹1.00 per share on 19 May 2026 - translating a dividend yield of 0.09%.

    Read More about Dividends

Indices Featuring Zydus Lifesciences Stock

Check stock indices that include Zydus Lifesciences.

NIFTY PHARMA

₹26,478.10

-180.55 (▲0.68%)

S&P BSE 150 MidCap

₹17,097.94

-0.97 (▲0.01%)

S&P BSE Dividend Stability

₹1,017.02

-1.89 (▲0.19%)

Nifty 200

₹13,908.50

-2.70 (▲0.02%)

S&P BSE 400 MidSmallCap

₹12,843.65

+10.28 (▲0.08%)

Nifty100 Quality

₹5,617.85

-19.70 (▲0.35%)

Nifty Healthcare

₹16,408.05

-144.15 (▲0.87%)

Nifty LargeMidcap 250

₹16,654.90

-15.80 (▲0.09%)

BSE 500

₹36,385.87

+70.06 (▲0.19%)

Nifty Next 50

₹72,880.90

-170.95 (▲0.23%)

Nifty100 Eq Weig

₹34,622.85

+4.80 (▲0.01%)

NIFTY 100

₹25,023.15

+9.70 (▲0.04%)

BSE 200

₹11,250.17

+24.62 (▲0.22%)

BSE Healthcare

₹50,913.20

-254.56 (▲0.50%)

Nifty 500

₹23,254.15

+0.10 (▲0%)

S&P BSE 250 LargeMidCap

₹10,731.82

+19.99 (▲0.19%)

Insights on Zydus Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 75.00% to 75.01% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 6.23K Cr → 8.12K Cr (in ₹), with an average increase of 8.4% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.88% to 5.12% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 168.5% return, outperforming this stock by 84.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 37.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ZYDUSLIFE stock has moved down by -4.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.86% to 6.83% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.27K Cr → 939.8 Cr (in ₹), with an average decrease of 26.2% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.95% to 6.88% in Jun 2026 quarter

Zydus Lifesciences Stock Futures & Options Contracts

View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.

Zydus Lifesciences Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 29 Sep ₹1200 Call
September 29, 2026
₹1200
₹7.6
-2.7
-26.21%
ZYDUSLIFE 29 Sep ₹1140 Call
September 29, 2026
₹1140
₹23.45
-7.15
-23.37%
ZYDUSLIFE 29 Sep ₹1220 Call
September 29, 2026
₹1220
₹5.1
-1.9
-27.14%
ZYDUSLIFE 29 Sep ₹1150 Call
September 29, 2026
₹1150
₹19.65
-5.9
-23.09%

Zydus Lifesciences Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 29 Sep Fut
September 29, 2026
-
₹1132
-13.52
-1.18%
ZYDUSLIFE 27 Oct Fut
October 27, 2026
-
₹1136.5
-14.04
-1.22%
ZYDUSLIFE 23 Nov Fut
November 23, 2026
-
₹1145
-10.87
-0.94%

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is a leading pharmaceutical company headquartered in Ahmedabad, India. Incorporated in 1995, the company operates in a number of lines of business, including active pharmaceutical ingredients, formulations, biotechnology, and nutraceuticals.

The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.

Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.

Revenue: ₹7,802.00Cr as on June 2026 (Q1 FY27)
Net Profit: ₹952.40Cr as on June 2026 (Q1 FY27)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
OrganisationZydus Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOPankaj R Patel
E-voting on sharesClick here to vote

FAQs

What is Zydus Lifesciences share price today?

Zydus Lifesciences share price today stands at ₹1120 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹1146 and a low of ₹1120.

What is the 52 week high and 52 week low range for Zydus Lifesciences share?

Zydus Lifesciences touched a 52 week high of ₹1205 and a 52 week low of ₹835.5. Zydus Lifesciences share price today i.e. is closed at ₹1120, which is -7.05% down from its 52 week high and 34.05% up from its 52 week low.

What is Zydus Lifesciences's market capitalisation today?

Zydus Lifesciences market capitalisation is ₹1,11,720.43 Cr as on .

How to buy Zydus Lifesciences shares?

To buy Zydus Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Zydus Lifesciences trading volume today?

Zydus Lifesciences trading volume is 5.17L as on . This means that 5.17L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.